Physicians' Academy for Cardiovascular Education

The future perspectives for care for patients with high Lp(a)

May 27, 2016 - Innsbruck, Germany - Prof. Erik Stroes, MD PhD – Academic Medical Center, Amsterdam, The Netherlands - FRIDAY, MAY 27, 2016, lunch symposium at Lp(a) symposium prior to EAS

Video navigation menu

  • Elevated Lp(a) levels are prevalent and associated with elevated CV risk 0:01
  • Elevated Lp(a) levels may be implicated in those with unexplained CV risk 1:28
  • What is needed to improve care for individuals with high Lp(a) levels? 3:09
  • Proposed underlying pathogenic pathways of Lp(a)'s atherogenicity 3:46
  • Identifying subjects and high-risk families 5:40
  • Therapeutic options to lower Lp(a) 7:01

Disclosures

Prof. Erik Stroes MD PhD – is Chairman, Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, The Netherlands

Funding

The PACE foundation received funding for this session via an unrestricted educational grant from Amgen